APA

Defreyne J., Vantomme B., Van Caenegem E., Wierckx K., De Blok C. J. M., Klaver M., Nota N. M., Van Dijk D., Wiepjes C. M., Den Heijer M. & T'Sjoen G. (20190403). Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. : Andrology.

Chicago

Defreyne J, Vantomme B, Van Caenegem E, Wierckx K, De Blok C J M, Klaver M, Nota N M, Van Dijk D, Wiepjes C M, Den Heijer M and T'Sjoen G. 20190403. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. : Andrology.

Harvard

Defreyne J., Vantomme B., Van Caenegem E., Wierckx K., De Blok C. J. M., Klaver M., Nota N. M., Van Dijk D., Wiepjes C. M., Den Heijer M. and T'Sjoen G. (20190403). Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. : Andrology.

MLA

Defreyne J, Vantomme B, Van Caenegem E, Wierckx K, De Blok C J M, Klaver M, Nota N M, Van Dijk D, Wiepjes C M, Den Heijer M and T'Sjoen G. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. : Andrology. 20190403.